2014-0242

A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (GBM)

Description

The purpose of this study is to establish the safety, tolerability and efficacy of nivolumab and nivolumab in combination with ipilimumab versus standard of care treatment (bevacizumab) in patients diagnosed with recurrent glioblastoma.

Additional information on this study from ClinicalTrials.gov